CONNECT WITH US
AI & Deeptech

AI & Deeptech

MIT-led team receives funding to develop next-generation alternatives to modern weed killers

MIT News – AI logo

Published on

Add as a preferred source on Google
MIT-led team receives funding to develop next-generation alternatives to modern weed killers

MIT researchers will lead an up to $53 million effort, awarded by the U.S. Advanced Research Projects Agency for Health (ARPA-H) as part of its STREAM (Systems for Tracking and Resilience in Efficient Agricultural-input Management) program, to develop next-generation weed killers that help farmers and protect human health. 

More than 1 billion pounds of herbicide are used in the United States every year. Herbicides help farmers by preventing significant crop loss due to weeds, and they enable regenerative farming practices that protect the soil, but some weeds are becoming resistant to the most common herbicides. 

Exposure to herbicides may contribute to increased risk of cancer, metabolic and endocrine disorders, and other adverse health outcomes. Farm workers can be exposed from frequent herbicide use, but many U.S. residents are also exposed to these chemicals in small amounts through food and drinking water. 

The MIT-led research team will develop new generative artificial intelligence tools to help them discover herbicide alternatives that are more effective and developed with human health in mind. Such alternatives could also help to reduce U.S. dependency on imported phosphorus, which is a critical ingredient in a major herbicide, glyphosate.

“With herbicides like glyphosate and atrazine, there’s a real crisis because of resistance mutations that are coming,” says Christopher Voigt, head of MIT’s Department of Biological Engineering.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.